Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P16104 (
H2AX
)
3,930
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously reported that protein kinase A activity is an important determinant of thyroid cell survival. Given the important role of
cAMP response element binding protein
(
CREB
) in mediating the transcriptional effects of protein kinase A, we explored whether interference with
CREB
family members impaired thyroid cell survival. Expression of A-
CREB
, a dominant-negative
CREB
mutant that inhibits
CREB
DNA binding activity, induced apoptosis in rat thyroid cells. A-
CREB
inhibited CRE-regulated gene expression but failed to alter the expression of bcl-2 family members or of well-characterized inhibitors of apoptosis. To elucidate the mechanism through which impaired
CREB
function triggered apoptosis, its effects on cell proliferation were examined. Expression of A-
CREB
inhibited cell number increases, in part due to delayed cell cycle transit. Protracted S-phase progression in A-
CREB
-expressing cells was sufficient to activate a checkpoint response characterized by Chk-1,
histone H2A.X
, and p53 phosphorylation. To determine whether cell cycle progression was required for apoptosis, the effects of p27 overexpression were investigated. Overexpression of p27 prevented cell cycle progression, checkpoint activation, and apoptosis in A-
CREB
-expressing cells. These data reveal a novel mechanism through which interference with
CREB
abrogates cell survival, through checkpoint activation secondary to cell cycle delay. This study may explain how interference with
CREB
induces apoptosis in cells where alterations in the expression of pro- and anti-survival genes are not detected.
...
PMID:Interference with 3',5'-cyclic adenosine monophosphate response element binding protein stimulates apoptosis through aberrant cell cycle progression and checkpoint activation. 1641 Mar 15
The mechanisms whereby bile acid reflux may accelerate the progression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EA) are not fully understood. In this study we found that bile acid taurodeoxycholic acid (TDCA) significantly increased the tail moment (TM) and histone
H2AX
phosphorylation in FLO-1 EA cells, an increase which was significantly decreased by knockdown of TGR5. Overexpression of TGR5 significantly increased TDCA-induced TM increase and
H2AX
phosphorylation. In addition, NADPH oxidase inhibitor diphenylene iodonium significantly inhibited the TDCA-induced increase in TM and
H2AX
phosphorylation. TDCA-induced increase in TM and
H2AX
phosphorylation was significantly decreased by knockdown of NOX5-S and overexpression of NOX5-S significantly increased TDCA-induced increase in the tail moment and
H2AX
phosphorylation. Furthermore, TDCA significantly increased
cAMP response element binding protein
(
CREB
) phosphorylation in FLO-1 cells. Knockdown of
CREB
significantly decreased TDCA-induced increase in NOX5-S mRNA and the tail moment. Conversely, overexpression of
CREB
significantly increased TDCA-induced TM increase. We conclude that TDCA-induced DNA damage may depend on the activation of TGR5,
CREB
and NOX5-S. It is possible that in Barrett's patients bile acids may activate NOX5-S and increase reactive oxygen species (ROS) production via activation of TGR5 and
CREB
. NOX5-S-derived ROS may cause DNA damage, thereby contributing to the progression from BE to EA.
...
PMID:Bile acid receptor TGR5, NADPH Oxidase NOX5-S and CREB Mediate Bile Acid-Induced DNA Damage In Barrett's Esophageal Adenocarcinoma Cells. 2751 Oct 66